Trio_specs_us_1-18-06 revc

Trio_specs_US_1-18-06 RevC 2/1/06 12:35 PM Page 1 T

G e n e r a l D e s c r i p t i o n
The Trio is a portable, configured monitor designed for use in many hospital departments and outpatient areas – from traditional bedside monitoring to intra-hospital transport. Its high- resolution color display far exceeds the standard The Trio, with a rechargeable battery, allows you to continuously monitor vital signs while transporting S u m m a r y o f F e a t u r e s a n d B e n e f i t s
■ 8.4'' color TFT display with a resolution of 800 x 600 provides optimal visualization of ■ Standard features include up to 4 waveforms, 3 or 5 lead ECG, Respiration, NIBP, SpO2 and ■ Many options available including Masimo SET® motion tolerant SpO2, Nellcor® OxiMax® SpO2, invasive blood pressure, Lithium Ion battery and ■ 24 hour graphic and list trends with event markers provide extended review of all patient ■ Default menu stores user configured settings for ■ Waveform and numeric data are configurable to ■ Ergonomically designed fold-away handle with ■ Built-in Power Supply for direct AC connection allows for convenient transport from one ■ Navigator™ Control Knob and quick action keys Trio_specs_US_1-18-06 RevC 2/1/06 12:35 PM Page 2 TrioTM P E R F O R M A N C E S P E C I F I C A T I O N S

P u l s e O x i m e t r y
Masimo SET® SpO2 Saturation Accuracy with no motion conditions Masimo SET® SpO2 Saturation Accuracy during motion conditions 20 seconds to 95% of final step of % SpO2 value from 60–95% at 75 BPM. Averaging set at 8 seconds.
Nellcor® OxiMax® SpO2 Saturation Accuracy MAX-A, MAX-AL, MAX-N, MAX-P, MAX-I, MAX-FAST Pulse Rate Range Masimo with no motion conditions Pulse Rate Range Masimo during motion conditions H e a r t R a t e M e t e r
E l e c t r i c a l R a t i n g s
Rejects all pulses of amplitude ±2.0 mV to ±700 mV and duration 0.1 ms to 2 ms with no tail per ANSI/AAMI EC13-2002 Rejects all pulses of amplitude ±2.0 mV to ±700 mV and duration 0.1 ms to 2 ms with 100 ms time constant tail of less than 2.0 mV, or 4 ms time constant tail of less than 2.0 mV per ANSI/AAMI EC13-2002 Tall T-Wave Rejection: Rejects all T-Waves less than 120% of a 1 mV, 100 ms QRS, and a T-Wave duration of 180 ms and a Q-T interval of 350 ms per ANSI/AAMI Sealed Lead Acid: 75 minutes from one fully charged new battery at 25 °C with ECG, SpO2, and NIBP every 15 minutes.
Lithium Ion: 3 hours from one fully charged new battery at 25 °C with ECG, SpO E n v i r o n m e n t a l C o n d i t i o n s
-1,000 to 20,000 ft ASL, 1050 hPa to 466 hPa, 788 mmHg to 349 mmHg I B P I n f o r m a t i o n
-1,000 to 9,889 ft ASL, 1050 hPa to 700 hPa, 788 mmHg to 525 mmHg ART: 0-150 mmHg, PA: 0-100 mmHg, CVP: 0-40 mmHg, RAP:0-40 Frequency Response: DC to 16 Hz ± 1 Hz, -3 db 4 kg (8.8 lbs) excluding battery & optional accessories 4.66 kg (10.25 lbs) including 1 sealed lead acid battery excluding optional accessories 25 ms, without sensor, measured using a simulator as the input 4.33 kg (9.52 lbs) including 1 lithium ion battery excluding optional accessories A g e n c y C o m p l i a n c e s
N o n - I n v a s i v e B P
This monitor complies with the following industry standards: IEC 60601-1:1988 +A1:1991, A2:1995/EN 60601-1:1990 +A1:1993, A2:1995, Measurement Intervals: 1 min, 2 min, 3 min, 4 min, 5 min, 10 min, 15 min, 30 min, 1 hr, A13:1995, UL 2601-1:1997, CSA Standard C22.2 No.601.1M90, IEC 60601-1-4:1996/ EN 60601-1-4:1996 + A1:1999, IEC 60601-2-30:1999/EN 60601-2-30:2000, Adult: 40-255 mmHg Pediatric: 40-200 mmHg IEC 60601-2-34:2000/EN 60601-2-34:2000, IEC 60601-2-27:1994/ Adult: 10-210 mmHg Pediatric: 10-150 mmHg Mean Error less than ±5 mmHg, Standard Deviation less than ±8 mmHg Mean Error less than ±5 mmHg, Standard Deviation less than ±8 mmHg EN 865:1997, EN 1060-1:1995, EN 1060-3:1997, ANSI/AAMI EC13:2002, ISO 3744:1994, ANSI/AAMI/ISO 10993-1:1997, AAMI SP10:1992, EN 475:1995, EN 1041:1998, EN 980:1996 + A1:1999 + A2:2001, IEC 878:1998, ISO 1000:1992 + A1:1998 T e m p e r a t u r e
IEC 60601-1-2:2001/EN 60601-1-2:2001, IEC 68-2-6:1982 +A1:1983 +A2:1985, IEC 68-2-27:1987, IEC 68-2-37:1973 +A1:1983, IEC 529: 1989, ISTA: 1998 Procedure 1A, ECRI PB-296892:1979 (Drop and impact) ± 0.1 °C (0–50 °C) exclusive of probe errors± 0.2 °F (32–122 °F) exclusive of probe errors Datascope Corp., US, Canada & Latin America
Patient Monitoring Division
R e s p i r a t i o n ( E C G )
800 MacArthur Boulevard Mahwah, NJ 07430-0619Customer Service: 1.800.288.2121 or 201.995.8000 Adult: 6–120 BPM, Pediatric: 6–150 BPM ± 2% or ± 2 breaths per minute, whichever is greater
Trio™ and Navigator™ are U.S. trademarks of Datascope Corp. Masimo SET® is a U.S. registered trademark of Masimo R e c o r d e r
Corp. Nellcor® and OxiMax® are registered trademarks of Nellcor Puritan Bennett Inc.
Subject to change.


Cp07036 - aleida h. konynenbelt vs minister of human resources development

THE PENSION APPEALS BOARD IN RE THE CANADA PENSION PLAN BETWEEN: ALEIDA H. KONYNENBELT Appellant MINISTER OF HUMAN RESOURCES DEVELOPMENT Respondent Appeal CP07036 The Honourable Mr. Justice F.H. Poulin, Chairman The Honourable John J. Urie for the Board : The Appellant appeals the majority decision of a Review Tribunal dated April 14, 1997, which confir


Comparison Of Current Pharmacotherapy For Nicotine Dependence Treatment** Rx Bupropion HCI OTC Nicotine Patch OTC Nicotine Gum and Lozenge Rx Nicotine Spray Rx Nicotine Inhaler Varenicline SR Tablet BRAND NAME PRODUCT STRENGTHS INITIAL DOSING 1–2 doses/hour (1 dose = 2 sprays per nostril) MAX DOSING TIME TO PEAK PLASMA LEVEL RECOMMENDED TREATMENT DURATION

Copyright © 2010 Medicament Inoculation Pdf